CHC Healthcare Group (TW:4164) — Market Cap & Net Worth
Market Cap & Net Worth: CHC Healthcare Group (4164)
CHC Healthcare Group (TW:4164) has a market capitalization of $160.30 Million (NT$5.09 Billion) as of August 3, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #17323 globally and #859 in its home market, demonstrating a -4.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CHC Healthcare Group's stock price NT$26.05 by its total outstanding shares 195311000 (195.31 Million). See CHC Healthcare Group capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
CHC Healthcare Group Market Cap History: 2015 to 2026
CHC Healthcare Group's market capitalization history from 2015 to 2026. Data shows change from $273.00 Million to $160.30 Million (-4.90% CAGR).
CHC Healthcare Group Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CHC Healthcare Group's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
CHC Healthcare Group's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.27x
CHC Healthcare Group's market cap is 1.27 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $209.41 Million | $2.21 Billion | $158.93 Million | 0.09x | 1.32x |
| 2017 | $173.88 Million | $2.12 Billion | -$86.69 Million | 0.08x | N/A |
| 2018 | $156.31 Million | $2.51 Billion | $323.42 Million | 0.06x | 0.48x |
| 2019 | $212.41 Million | $2.95 Billion | $395.17 Million | 0.07x | 0.54x |
| 2020 | $217.68 Million | $2.55 Billion | $366.39 Million | 0.09x | 0.59x |
| 2021 | $221.41 Million | $2.44 Billion | $381.63 Million | 0.09x | 0.58x |
| 2022 | $267.98 Million | $2.97 Billion | $356.57 Million | 0.09x | 0.75x |
| 2023 | $375.97 Million | $3.88 Billion | $418.87 Million | 0.10x | 0.90x |
| 2024 | $257.21 Million | $3.60 Billion | $168.38 Million | 0.07x | 1.53x |
| 2025 | $236.90 Million | $4.40 Billion | $186.28 Million | 0.05x | 1.27x |
Competitor Companies of 4164 by Market Capitalization
Companies near CHC Healthcare Group in the global market cap rankings as of August 3, 2026.
Key companies related to CHC Healthcare Group by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #272 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #525 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #624 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1092 globally with a market cap of $24.01 Billion USD ( AU$33.94 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #272 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $856.19 |
| #525 | Cencora Inc. | NYSE:COR | $50.53 Billion | $311.34 |
| #624 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $230.03 |
| #1092 | Sigma Healthcare Ltd | AU:SIG | $24.01 Billion | AU$2.94 |
CHC Healthcare Group Historical Marketcap From 2015 to 2026
Between 2015 and today, CHC Healthcare Group's market cap moved from $273.00 Million to $ 160.30 Million, with a yearly change of -4.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$160.30 Million | -32.34% |
| 2025 | NT$236.90 Million | -7.89% |
| 2024 | NT$257.21 Million | -31.59% |
| 2023 | NT$375.97 Million | +40.30% |
| 2022 | NT$267.98 Million | +21.03% |
| 2021 | NT$221.41 Million | +1.72% |
| 2020 | NT$217.68 Million | +2.48% |
| 2019 | NT$212.41 Million | +35.89% |
| 2018 | NT$156.31 Million | -10.10% |
| 2017 | NT$173.88 Million | -16.97% |
| 2016 | NT$209.41 Million | -23.29% |
| 2015 | NT$273.00 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of CHC Healthcare Group was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $160.30 Million USD |
| MoneyControl | $160.30 Million USD |
| MarketWatch | $160.30 Million USD |
| marketcap.company | $160.30 Million USD |
| Reuters | $160.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CHC Healthcare Group
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitatio… Read more